Hepatocellular carcinoma imaging: Exploring traditional techniques and emerging innovations for early intervention  

作　　者：Hariharan Thirumalai Vengateswaran Mohammad Habeeb Huay Woon You Kiran Balasaheb Aher Girija Balasaheb Bhavar Govind Sarangdhar Asane 

机构地区：[1]Department of Pharmaceutics,Crescent School of Pharmacy,B.S.Abdur Rahman Crescent Institute of Science and Technology,Chennai,600048,India [2]Pusat PERMATA@Pintar Negara,Universiti Kebangsaan Malaysia,43600,Bangi,Selangor,Malaysia [3]Department of Pharmaceutical Quality Assurance,Shri Vile Parle Kelavani Mandal's Institute of Pharmacy,Dhule,Maharashtra,424001,India [4]Department of Pharmaceutical Chemistry,Shri Vile Parle Kelavani Mandal's Institute of Pharmacy,Dhule,Maharashtra,424001,India [5]Department of Pharmaceutics,St.John Institute of Pharmacy and Research,Palghar,Maharashtra,401404,India

出　　处：《Medicine in Novel Technology and Devices》2024年第4期20-37,共18页医学中新技术与新装备(英文)

摘　　要：Hepatocellular carcinoma(HCC)continues to be a diagnostic and therapeutic challenge for healthcare systems around the world in addition to being a significant contributor to oncologic mortality.To improve the standard of life and the survival of patients,early diagnosis of the condition and subsequent appropriate treatment are essential.Hepatocellular carcinoma(HCC)observation,early detection,diagnosis,and follow-up all depend heavily on imaging modalities.They provide valuable information about the characteristics of HCC nodules,aiding in non-invasive diagnosis and staging.Imaging has evolved beyond simply confirming a suspected diagnosis in the management of hepatocellular carcinoma(HCC).Several traditional imaging modalities,including PET/CT,MRI,MR elastography,ultrasound(US),and endoscopy,along with next-generation imaging modalities such as photoacoustic imaging,and Cerenkov luminescence with the utilization of contrasting agents further enhance their diagnostic capabilities in HCC.The selection of the most appropriate imaging modality and contrasting agent depends on various factors,including the clinical scenario,patient characteristics,and availability of resources.In addition to these advancements,artificial intelligence(AI)has developed as a valuable tool in radiology for the management of HCC.In this review,we highlighted the most important imaging techniques for managing patients with a high risk of HCC.

关 键 词：Hepatocellular carcinoma Oncological imaging ULTRASOUND DIAGNOSIS Artificial intelligence 

分 类 号：R73[医药卫生—肿瘤]